# Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm

> **NCT04355247** · PHASE2 · UNKNOWN · sponsor: **Auxilio Mutuo Cancer Center** · enrollment: 20 (estimated)

## Conditions studied

- Covid-19

## Interventions

- **DRUG:** MethylPREDNISolone 80 Mg/mL Injectable Suspension

## Key facts

- **NCT ID:** NCT04355247
- **Lead sponsor:** Auxilio Mutuo Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-14
- **Primary completion:** 2020-07-31
- **Final completion:** 2021-04-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2020-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04355247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04355247, "Prophylactic Corticosteroid to Prevent COVID-19 Cytokine Storm". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04355247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*